Top

Published in:

01-03-2012 | Epidemiology (J Gelfand, Section Editor)

A Review of the Epidemiology of Cardiovascular Comorbidities in Psoriasis

Authors: Sungwon Lee, Jashin J. Wu

Published in: Current Dermatology Reports | Issue 1/2012

Abstract

Several epidemiologic studies suggest that there is an association between psoriasis and cardiovascular comorbidities, possibly due to overall systemic inflammation. Psoriasis is an independent risk factor for cardiovascular disease and mortality that is also associated with many of the traditional cardiovascular risk factors. This article summarizes important studies that demonstrate an association between psoriasis with smoking and alcohol intake, as well as increased risk of psoriasis patients for atrial fibrillation, atherosclerosis, coronary artery calcification, type 2 diabetes, dyslipidemia, hypertension, metabolic syndrome, obesity, peripheral vascular disease, myocardial infarction, stroke, and cardiac death.

Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141:1537–41.PubMedCrossRef

Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc. 2004;9:136–9.CrossRef

Neimann AL, Porter SB, Gelfand JM. Epidemiology of psoriasis. Expert Rev Dermatol. 2006;1:63–75.CrossRef

Christophers E. Comorbidities in psoriasis. Clin Dermatol. 2007;25:529–34.PubMedCrossRef

Ahlehoff O, Gislason GH, Jorgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish nationwide cohort study. Eur Heart J. 2011, In press.

Kimball AB, Robinson Jr D, Wu Y, et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology. 2008;217(1):27–37.PubMedCrossRef

Black PH. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun. 2003;17:350–64.PubMedCrossRef

Rhew EY, Ramsey-Goldman R. Premature atherosclerotic disease in systemic lupus erythematosus-role of inflammatory mechanisms. Autoimmun Rev. 2006;5:101–5.PubMedCrossRef

Asanuma Y, Chung CP, Oeser A, et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol. 2006;33:539–45.PubMed

10.

Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2007;56(4):629–34.PubMedCrossRef

11.

• Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145(6):700–3. This article provides important information on the increased risk of atherosclerotic vascular diseases, including cerebrolvascular disease, ischemic heart disease, and peripheral vascular disease, in patients with psoriasis. PubMedCrossRef

12.

Wakkee M, Meijer W, Neumann M, et al. Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study. Acta Derm Venereol. 2009;89:476–83.PubMedCrossRef

13.

Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol. 2008;159(4):895–902.PubMedCrossRef

14.

Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol. 2007;156(2):271–6.PubMedCrossRef

15.

Boehncke WH, Boehncke S, Tobin AM, et al. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20:303–7.PubMedCrossRef

16.

Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–41.PubMedCrossRef

17.

Choi WJ, Park EJ, Kwon IH, et al. Association between psoriasis and cardiovascular risk factors in Korean patients. Ann Dermatol. 2010;22:300–6.PubMedCrossRef

18.

• Qureshi AA, Choi HK, Setty AR, et al. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009;145(4):379–82. The findings in this article provide important information on the increased prevalence of developing diabetes and hypertension in patients with psoriasis. PubMedCrossRef

19.

Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol. 2008;159(6):1331–7.PubMedCrossRef

20.

Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001;303:33–9.PubMedCrossRef

21.

• Koebnick C, Black MH, Smith N, et al. The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr. 2011;159:577–83. This article provides up-to-date information on the association between psoriasis and cardiovascular risk factors in overweight to extremely obese children, as well the trend between psoriasis and weight class. PubMedCrossRef

22.

Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32:982–6.PubMedCrossRef

23.

Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172:298–304.PubMedCrossRef

24.

Armstrong A, Lin SW, Chambers C, et al. Psoriasis and hypertension severity: results from a case-control study. PLoS One. 2011;6(3):e18227. doi:10.1371/journal.pone.0018227.PubMedCrossRef

25.

Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003–2006. Arch Dermatol. 2011;147(4):419–24.PubMedCrossRef

26.

Ozturkcan S, Ermertcan AT, Sekuri C, et al. Cardiovascular findings in patients with psoriasis. Ann Saudi Med. 2006;26:159–61.PubMed

27.

Mallbris L, Granath F, Hamten A, et al. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54:614–21.PubMedCrossRef

28.

Boehncke S, Thaci D, Beschmann H, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007;157:1249–51.PubMedCrossRef

29.

Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527–34.PubMedCrossRef

30.

Setti AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Arch Int Med. 2007;167(15):1670–5.CrossRef

31.

Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61–7.PubMedCrossRef

32.

Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med. 2007;120(11):953–9.PubMedCrossRef

33.

Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol. 1999;135(12):1490–3.PubMedCrossRef

34.

• Qureshi AA, Dominguez PL, Choi HK, et al. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol. 2010;146(12):1364–9. This article provides important information on the association between alcohol consumption and an increased risk of developing psoriasis in women. PubMedCrossRef

35.

• Xiao J, Chen LH, Tu YT, et al. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009;23(11):1311–5. The findings in this article show a higher prevalence of myocardial infarction in both mild and severe psoriasis than in patients without psoriasis in central China. PubMedCrossRef

36.

• Mehta NN, Yu Y, Pinnelas R, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124(8):775. This article provides important information on major adverse cardiac events associated with severe psoriasis. PubMedCrossRef

37.

Ahlehoff O, Gislason GH, Lindhardsen J, et al. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study. J Intern Med. 2011;270(3):237–44.PubMedCrossRef

38.

• Lin HW, Wang KH, Lin HC, et al. Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. J Am Acad Dermatol. 2011;64(3):495–501. This article provides important information on independent risk of acute myocardial infarction in Asian psoriatic populations. PubMedCrossRef

39.

• Gladman DD, Ang M, Su L, et al. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis. 2009;68:1131–5. This article summarizes important information on increased risk of cardiovascular morbidities in patients with psoriatic arthritis compared with the general population. PubMedCrossRef

40.

Stern R. Psoriasis is not a useful independent risk factor for cardiovascular disease. J Invest Dermatol. 2010;130:917–9.PubMedCrossRef

41.

Helfand M, Buckley DI, Freeman M, et al. Emerging risk factors for coronary heart disease: a summary of systemic reviews conducted for the U.S. preventive services task force. Ann Intern Med. 2009;151:496–507.PubMed

42.

Stern R, Huibregtse A. Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. J Invest Dermatol. 2011;131:1159–66.PubMedCrossRef

43.

• Gelfand JM, Mehta NN, Langan SM. Psoriasis and cardiovascular risk: strength in numbers, part II. J Invest Dermatol. 2011;131:1007–10. This article provides a detailed rebuttal to the article by Stern and Huibregtse [42] that suggests there is no increased cardiovascular risk in severe psoriasis. PubMedCrossRef

44.

Wakkee M, Herings R, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based dutch cohort. J Invest Dermatol. 2010;130:962–7.PubMedCrossRef

45.

Schmitt J, Ford DE. Psoriasis is independently associatd with psychiatry morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol. 2010;24(8):885–92.PubMedCrossRef

46.

•• Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009;129(10):2411–8. The findings in this article provide new and interesting information on the positive association between psoriasis and the risk of stroke. PubMedCrossRef

47.

D’Agostino RB, Wolf PA, Belanger AJ, et al. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40–3.PubMedCrossRef

48.

Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis. Arch Dermatol. 2007;143:1493–9.PubMedCrossRef

49.

•• Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31:1000–6. The findings in this article provide important information on the increased risk of cardiovascular mortality independent of traditional cardiovascular risk factors in patients with psoriasis. PubMedCrossRef

50.

• Abuabara K, Azfar RS, Shin DB, et al. Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the United Kingdom. Br J Dermatol. 2010;163(3):586–92. This article summarizes important information on increased risk of death from cardiovascular diseases, malignancies, chronic obstructive pulmonary disease, diabetes, dementia, infection, kidney disease, and unknown/missing causes in patients with severe psoriasis. PubMedCrossRef

Title: A Review of the Epidemiology of Cardiovascular Comorbidities in Psoriasis
Authors: Sungwon Lee
Jashin J. Wu
Publication date: 01-03-2012
Publisher: Current Science Inc.
Published in: Current Dermatology Reports / Issue 1/2012
Electronic ISSN: 2162-4933
DOI: https://doi.org/10.1007/s13671-011-0005-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A Review of the Epidemiology of Cardiovascular Comorbidities in Psoriasis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

Current Developments in Viral Skin Diseases

Epidemiology of Cosmetic Procedures: An Update for Dermatologists

The Epidemiology and Prevention of Herpes Zoster

Impact of Long-Term Antibiotic Use for Acne on Bacterial Ecology and Health Outcomes: A Review of Observational Studies

Comorbidity in Atopic Dermatitis